New Delhi (PTI): Gujarat Titans on Monday appointed Shubman Gill as their captain for the 2024 season of the Indian Premier League (IPL) following Hardik Pandya's decision to move back to Mumbai Indians.
The Gujarat Titans will receive Rs 15 crore from MI for the all-cash trade deal apart from a hefty undisclosed transfer fee, a part of which will also go to the cricketer.
Once Pandya's exit was sure, 24-year-old opener Gill was an obvious captaincy choice, having got the coveted 'orange cap' in the last season with 890 runs, second to only Virat Kohli's all-time record of 973.
"I am delighted and proud to assume the captaincy of Gujarat Titans and thank the franchise for their trust in me to lead such a fine team. We have had two exceptional seasons and I keenly look forward to leading the team with our exciting brand of cricket," Gill said in a statement.
GT Team Director Vikram Solanki acknowledged Pandya's contribution to the team's success in then last two seasons.
"As the first captain of Gujarat Titans, Hardik Pandya has helped the franchise deliver two fantastic seasons that resulted in winning one IPL championship and one appearance in the final," Solanki was quoted as saying in a statement.
"He has now expressed a desire to return to his original team Mumbai Indians. We respect his decision and wish him all the very best in his future endeavours," the former England batter further added.
Solanki, who has closely worked with the Gill, vouched for his maturity.
"Shubman Gill has shown growth in stature and standing over the last two years at the highest level of the game. We've seen him mature not only as a batter but also as a leader in cricket," Solanki opined.
"His maturity and skill is evident in his on-field performance and we are extremely excited to embark on a new journey with a young leader like Shubman at the helm," the head of GT think-tank said.
Let the Truth be known. If you read VB and like VB, please be a VB Supporter and Help us deliver the Truth to one and all.
Bengaluru: The Karnataka Government has sought clarification from the Central drugs standard control organisation following reports linking the serial deaths of pregnant women at Ballari District Hospital to unsafe IV Ringer's Lactate solution. Health Department Principal Secretary Harsha Gupta has written a letter to the Drugs Controller General of India, Rajeev Singh Raghuvanshi.
Recent Investigations revealed bacterial and fungal contaminants in the IV solution given to the women. Out of 192 batches supplied by a West Bengal-based pharmaceutical company, 22 were found substandard by the state drug control department, leading to the suspension of the medicine's use.
However, these batches had passed quality tests at the Central Drug Lab, creating a regulatory conflict.
The Health Department emphasized adherence to tender rules, stating that the Central Drug Lab's approval is legally binding. Samples from the problematic batches have been sent for re-testing at the central lab in West Bengal, with results expected on December 9.
As a precautionary measure, the state has blacklisted the implicated batches and issued directives to halt their use in all hospitals.